Literature DB >> 9426735

Progressive angiomyolipoma with inferior vena cava tumor thrombus.

M R Bernstein1, S B Malkowicz, E S Siegelman, M Acker, J E Tomaszewski, A J Wein.   

Abstract

A 45-year-old man presented with an incidentally discovered benign renal angiomyolipoma. This lesion initially demonstrated renal vein involvement. On referral to our institution 3 years later, there was interval progression of tumor thrombus to the intrahepatic inferior vena cava. Intravascular extension of benign angiomyolipoma, though rare, has been reported. We present a new example and review the literature concerning this unusual complication of a common renal neoplasm.

Entities:  

Mesh:

Year:  1997        PMID: 9426735     DOI: 10.1016/s0090-4295(97)00454-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

1.  RENAL ANGIOMYOLIPOMA.

Authors:  B M Nagpal; N S Mani; R K Bajpai; M M Harjai; K J Singh
Journal:  Med J Armed Forces India       Date:  2017-06-12

2.  [Bilateral renal angiomyolipomas with a thrombus in the inferior caval vein. Rare growth pattern of a benign tumor].

Authors:  S Bierer; C Wülfing; M-E Bode; G Pühse; O-A Brinkmann; L Hertle
Journal:  Urologe A       Date:  2005-12       Impact factor: 0.639

Review 3.  A right renal angiomyolipoma with IVC thrombus and pulmonary embolism.

Authors:  Y S Tan; K H Yip; P H Tan; W S Cheng
Journal:  Int Urol Nephrol       Date:  2009-07-16       Impact factor: 2.370

4.  Renal angiomyolipoma with inferior vena caval thrombus in a 32-year-old male.

Authors:  Matthew W Christian; Timothy D Moon
Journal:  Indian J Urol       Date:  2009 Oct-Dec

5.  Nephron sparing surgery for renal angiomyolipoma with inferior vena cava thrombus in tuberous sclerosis.

Authors:  Adrien Riviere; Thomas Bessede; Jean-Jacques Patard
Journal:  Case Rep Urol       Date:  2014-02-23

6.  Aggressive renal angiomyolipoma with vena cava extension: A case report and literature review.

Authors:  Gang Shen; Qiqi Mao; Hanjin Yang; Chaojun Wang
Journal:  Oncol Lett       Date:  2014-08-08       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.